MedTrace Logo

TMS Stimulation and Cognitive Training in Alzheimer Patients

NCT01168245 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2013-03-28

No results posted yet for this study

Summary

The aim of this study is to examine if combined treatment with TMS and cognitive training (CoTra) for several weeks can produce a sustained improvement in cognitive and behavioral symptomatology of mild to moderate Alzheimer's disease (AD) patients.

Conditions

  • Alzheimer Disease
  • Mild to Moderate

Interventions

DEVICE

Sham-NICE-System

sham TMS and sham cognitive training

DEVICE

NICE-System

TMS combined with cognitive training

Sponsors & Collaborators

  • Assaf-Harofeh Medical Center

    collaborator OTHER_GOV

  • Neuronix Ltd

    lead INDUSTRY

Principal Investigators

  • Martin Rabey, Prof. · Assaf-Harofeh Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Israel

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01168245 on ClinicalTrials.gov